The effect of postoperative chemotherapy on survival outcomes and a nomogram for predicting overall survival in chondroblastic osteosarcoma
Ruicong Li, Huiying Wang, Weipeng Zheng, Ning Wang, Zekai Ma, Shifeng Wen · 2025
Read The effect of postoperative chemotherapy on survival outcomes and a nomogram for predicting overall survival in chondroblastic osteosarcoma by Ruicong Li, Huiying Wang, Weipeng Zheng, Ning Wang, Zekai Ma, Shifeng Wen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12749957.txt.
Description
Ruicong Li and co-authors test whether chemotherapy after surgery helps patients with chondroblastic osteosarcoma, a bone cancer subtype, using a national United States registry. The cohort held 317 surgically treated patients, of whom about 82 percent received chemotherapy. Median follow-up ran just over five years.
Chemotherapy patients survived longer overall, a gap that survived matching on background factors. Five-year survival was about 52 percent with chemotherapy against 48 percent without. Benefits concentrated in men, in high-grade tumors, and in higher-income patients. By stage, the gain was clear in early disease and faded in advanced stages. Age, stage, and radiotherapy predicted survival on their own. The team folded those factors plus marital status and chemotherapy into a nomogram, a scoring chart giving personal five-, ten-, and fifteen-year survival estimates. They offer it as a planning aid where subtype-specific tools were lacking.
Catalog record
| CREATOR | Ruicong Li, Huiying Wang, Weipeng Zheng, Ning Wang, Zekai Ma, Shifeng Wen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |